Company / EPS (Diluted)
AVITA Medical, Inc. EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$2.39
FY2025
5-year range
-$2.39 / $1.56
FY2021-FY2025
Trend
-70.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has declined for 4 consecutive years, from $1.56 in FY2021 to $-2.39 in FY2025.
Based on SEC 10-K filings.
-2.39 in FY2025.
Declined from $1.07 to $-2.39 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- AVITA Medical, Inc.'s eps (diluted) has declined for 4 consecutive years.
- In FY2025, eps (diluted) decreased 70.7% year-over-year.
- Peak eps (diluted) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.29 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.39 | -70.7% |
| FY2024 | -$1.40 | -230.8% |
| FY2023 | $1.07 | -8.5% |
| FY2022 | $1.17 | -25.0% |
| FY2021 | $1.56 | +13.9% |
| FY2020 | $1.37 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026